Baohua Lu

Beijing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Real-world evidence for immunotherapy in the first-line or subsequent-line setting in extensive-stage small-cell lung cancer.

Real-world evidence for immunotherapy in the first-line or subsequent-line setting in extensive-stage small-cell lung cancer.

Journal: Therapeutic advances in medical oncology
Published: July 22, 2025

A Phase II Trial of Perioperative Camrelizumab Plus Neoadjuvant Chemotherapy in Resectable Stage IIB-IIIB Lung Squamous Cell Carcinoma.

A Phase II Trial of Perioperative Camrelizumab Plus Neoadjuvant Chemotherapy in Resectable Stage IIB-IIIB Lung Squamous Cell Carcinoma.

Journal: MedComm
Published: May 16, 2025

Analysis of Acquired Fusion Mutations in EGFR-TKIs-Resistant Patients with Advanced Lung Cancer.

Analysis of Acquired Fusion Mutations in EGFR-TKIs-Resistant Patients with Advanced Lung Cancer.

Journal: Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
Published: March 02, 2025

The IASLC uncertain resection, general overview, current evidence, and future prospects: a systematic review and meta-analysis.

The IASLC uncertain resection, general overview, current evidence, and future prospects: a systematic review and meta-analysis.

Journal: Therapeutic advances in medical oncology
Published: December 08, 2024

Pre-treatment Circulating Tumor Cell Associated White Blood Cell Clusters Independently Predict Poor Survival in Patients with Extensive-disease Small Cell Lung Cancer.

Pre-treatment Circulating Tumor Cell Associated White Blood Cell Clusters Independently Predict Poor Survival in Patients with Extensive-disease Small Cell Lung Cancer.

Journal: Biomarker insights
Published: October 07, 2024

Disseminated tumor cells in bone marrow as predictive classifiers for small cell lung cancer patients.

Disseminated tumor cells in bone marrow as predictive classifiers for small cell lung cancer patients.

Journal: Journal of the National Cancer Center
Published: March 26, 2024

Integration of clinical and blood parameters in risk prognostication for patients receiving immunochemotherapy for extensive stage small cell lung cancer: real-world data from two centers.

Integration of clinical and blood parameters in risk prognostication for patients receiving immunochemotherapy for extensive stage small cell lung cancer: real-world data from two centers.

Journal: BMC medicine
Published: March 01, 2024

Easily applicable predictive score for MPR based on parameters before neoadjuvant chemoimmunotherapy in operable NSCLC: a single-center, ambispective, observational study.

Easily applicable predictive score for MPR based on parameters before neoadjuvant chemoimmunotherapy in operable NSCLC: a single-center, ambispective, observational study.

Journal: International journal of surgery (London, England)
Published: October 30, 2023

Longitudinal detection of subcategorized CD44v6+ CTCs and circulating tumor endothelial cells (CTECs) enables novel clinical stratification and improves prognostic prediction of small cell lung cancer: A prospective, multi-center study.

Longitudinal detection of subcategorized CD44v6+ CTCs and circulating tumor endothelial cells (CTECs) enables novel clinical stratification and improves prognostic prediction of small cell lung cancer: A prospective, multi-center study.

Journal: Cancer letters
Published: February 23, 2023

Post-therapeutic circulating tumor cell-associated white blood cell clusters predict poor survival in patients with advanced driver gene-negative non-small cell lung cancer.

Post-therapeutic circulating tumor cell-associated white blood cell clusters predict poor survival in patients with advanced driver gene-negative non-small cell lung cancer.

Journal: BMC cancer
Published: February 13, 2023

Interpretable deep learning survival predictive tool for small cell lung cancer.

Interpretable deep learning survival predictive tool for small cell lung cancer.

Journal: Frontiers in oncology
Published: February 09, 2023

Plasma hepatocyte growth factor as a noninvasive biomarker in small cell lung cancer.

Plasma hepatocyte growth factor as a noninvasive biomarker in small cell lung cancer.

Journal: BMC cancer
Published: November 10, 2022
Showing 1-12 of 17

Last Updated: 09/26/2026